Sector valuations Virax Biolabs Group Limited
Equities
VRAX
KYG9495L1251
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2125 USD | +7.27% |
|
+12.37% | -38.55% |
Main competitors
| P/E (N) | Price to Book (N) | PEG (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| -0.53x | - | 0.01x | - | - | - | - | 4.23M | ||
| 29.32x | 3.75x | 1.3x | 5.21x | 16.14x | 22.65x | 1.12% | 42.68B | ||
| -18.74x | 13.7x | -0.55x | 284.14x | -16.99x | -16.72x | -.--% | 31.73B | ||
| 22.28x | 4.23x | 4.43x | 2.56x | 11.07x | 16.87x | -.--% | 30.62B | ||
| 40.18x | 5.87x | 0.24x | 4.01x | 25.73x | 30.51x | -.--% | 30.03B | ||
| 28.96x | 2.16x | 0.87x | 7.47x | 19.23x | 23.02x | 0.42% | 24.25B | ||
| 22.57x | 2.36x | 0.78x | 1.96x | 8.6x | 13.62x | 1.18% | 13.17B | ||
| 26.66x | 13.35x | 2.32x | 4.26x | 19.41x | 20.35x | -.--% | 12.97B | ||
| -20.79x | 307.6x | -0.41x | 13.58x | -20.21x | -19.65x | -.--% | 12.31B | ||
| 23.79x | 1.17x | 0.2x | 1.71x | 10.36x | 11.87x | -.--% | 11.44B | ||
| -23.06x | 20.57x | -0.54x | 5.64x | 138.25x | -435.07x | -.--% | 8.34B | ||
| 29.56x | 2.65x | -0.1x | 2.74x | 10.69x | 12.97x | -.--% | 8.73B | ||
| 44.59x | 3.77x | 0.29x | 6.67x | 18.94x | 20.82x | 0.62% | 8.14B | ||
| -22.84x | 39.7x | 1.12x | 1736.22x | -24.76x | -25.37x | -.--% | 8.08B | ||
| 17.5x | 1.97x | 2.17x | 3.76x | 10.27x | 12.84x | -.--% | 7.59B | ||
| -16.68x | 6.32x | -1.29x | 1453.01x | -13.71x | -13.03x | -.--% | 7.08B | ||
| -107.81x | 3.87x | 0.84x | 4.47x | 23.7x | 142.19x | -.--% | 7.13B | ||
| -20.33x | 6.03x | -15.77x | 389.16x | -16.21x | -16.2x | -.--% | 6.51B | ||
| Average | 3.03x | 25.83x | -0.23x | 230.97x | 12.97x | -11.67x | 0.2% | 15.04B | |
| Weighted average by Cap. | 12.05x | 20.79x | 0.58x | 136.37x | 11.84x | 0.48x | 0.29% |
- Stock Market
- Equities
- VRAX Stock
- Sector Virax Biolabs Group Limited
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















